Pfizer Stock News

Pfizer says that several lab studies it has conducted indicate that its COVID-19 antiviral pill Paxlovid is effective against the Omicron variant.

Shares of vaccine makers, including Moderna Inc Full story available on Benzinga.com

A fourth dose of Pfizer and BioNTech''s Covid shot is only partly effective against omicron, according to a new test. The vaccine stocks fell.

New York, NY, and Tel Aviv, ISRAEL January 18, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF ) , a comprehensive medical diagnostics and related solutions company, today released videos of recent interviews with Fox Business, Black New Channel and NewsMax where CEO Gerald Commissiong discusses strategies for improving the current COVID testing paradigm in the United States and how this interplay with the effectiveness of emerging oral antiviral treatments, including Pfizers (NYSE: PFE ) Paxlovid® and Mercks (NYSE: MRK ) Mulnupiravir® that both received Emergency Use Authorization (EUA) from the US Food & Drug Administration in December 2021, as well as Todos investigational oral all natural botanical drug candidate Tollovir that will be reading out on Phase 2 clinical trial data for the treatment of hospitalized (severe/critical) COVID-19 patients on January 27 th , 2022. Links to the interviews can be found below. Fox Business on 1/11/22: https://www.youtube.com/watch?v=kbJTx-aiP4Q NewsMax on 1/15/22: https://www.youtube.com/watch?v=F3w6S0JYMfM Black New Channel on 1/17/22: https://www.youtube.com/watch?v=5TIFBsGV8pU As we raise the profile of what we are doing at Todos to help with the COVID-19 pandemic, we are committed to taking a non-political position, speaking with both Democrats and Republicans, and staying squarely rooted in making recommendations based on the best currently available data to promote the best use of the FDA-authorized tools at the publics disposal to help guide the population back towards normal life while the pandemic continues forward, said Gerald E.

Hong Kong Arrests Flight Attendants As Beijing Faces ''Dual Variant'' Outbreak Is the COVID pandemic really reaching its final stretch? That''s what Pfizer CEO Albert Bourla would like the public to believe - he said during a recent series of interviews with the French media that life on earth should "return to normal" in the coming months. Of course, the "experts" said the same thing last winter. But the reality on the ground shows that we''re a long way away. Globally, the number of new COVID cases has declined from a single-day peak reached earlier this month. Meanwhile, a growing number of governments are taking extreme measures to try and crack down on the virus. Japan is set to grant permission to the governors of Tokyo and 12 other prefectures to tighten restrictions on social activities as COVID-19 cases hit a daily record. Japan reported more than 27K new cases, broadcaster TBS said, exceeding the previous high seen in August shortly after Tokyo hosted the Summer Olympics. Elsewhere in Asia, authorities in Hong Kong have arrested two Cathay Pacific flight attendants for violating the city''s strict anti-pandemic policies.

Along with AbbVie Inc''s (NYSE: ABBV ) upadacitinib approval , the FDA approved Pfizer Inc''s (NYSE: PFE ) oral daily JAK1 inhibitor Cibinqo (abrocitinib) to treat adults with moderate to severe atopic dermatitis. The approval covers patients who have not been able to get their disease under control with other medicines, including biologics, and Full story available on Benzinga.com

Health Canada approved Pfizer Inc''s (NYSE: PFE ) oral antiviral treatment for mild to moderate cases of COVID-19 in adults. The approval covers adults with mild to moderate COVID-19 who are at high risk of progressing to hospitalization or death . The active ingredient nirmatrelvir in Paxlovid works by stopping the virus from replicating. Related: Pfizer''s Paxlovid Scores FDA Approval, First Oral Antiviral For … Full story available on Benzinga.com

Preliminary research shows fourth dose of the Pfizer vaccine boosted antibodies, but didn''t prevent Omicron infections.

Pfizer CEO Predicts Life On Earth "Will Return To Normal" In The Spring Just a few days ago, Bill Gates shared some of his (revised) thoughts on the COVID pandemic and the trajectory that omicron has left us on. Several weeks after warning that omicron''s heightened infectiousness might send the pandemic into overdrive , the Microsoft founder postulated instead that omicron might hasten the end of the pandemic by leaving the human population with more antibodies against the virus. As a result, SARS-CoV-2 might enter its endemic stage more quickly, Gates suggested. This view, that the end of the pandemic might finally be at hand after two years of suffering, has become increasingly popular as of late. Take this piece from the BBC : "Endemic COVID: Is the pandemic entering its endgame?". While the piece mostly focused on the UK, the sense is that the developed world more broadly is closer to the end because of its access to vaccines. So, is a new Covid-era truly imminent and what will that actually mean for our lives? "We''re almost there, it is now the beginning of the end, at least in the UK," Prof Julian Hiscox, chairman in infection and global health at the University of Liverpool, tells me. "I think life in 2022 will be almost back to before the pandemic." What''s changing is our immunity.

A fourth shot of Covid-19 vaccine boosts antibodies to even higher levels than the third jab but it is not enough to prevent Omicron infections, according to a preliminary study in Israel.Israels Sheba Medical Centre has given second booster shots in a trial among its staff and is studying the effect of the Pfizer booster in 154 people after two weeks and the Moderna booster in 120 people after one week, said Gili Regev-Yochay, director of the Infectious Diseases Unit.These were compared to a

Canadas health regulator has approved a pill by Pfizer that treats the effects of COVID-19

Rejected three times, Unilever suggests it will keep fighting to acquire a giant in the world of pain relievers, toothpastes and cold treatments.

Novasep announced an agreement with Pfizer (PFE) to help the global production of the COVID-19 pill, paxlovid, developed by the U.S

Malone: ''Mass Formation'' Deployed On You After Over 200 Years Of Study Authored by Robert Malone via "Who Is Robert Malone" Substack, Today in factchecking the factcheckers, junior academics cited by Forbes , Associated Press , Reuters and The Independent have just not done their homework concerning the work of Professor Dr. Mattias Desmet of the University of Ghent in Belgum. All I can say about this is that I hope that their naive, ignorant, grandstanding statements to the press are brought up during their future Academic Tenure and Advancement reviews. But there has been an amazingly coordinated effort to shoot the messenger and actively character assassinate (or defenstrate ) me as a surrogate while avoiding any reference to the highly credentialed academic Professor Dr. Mattias Desmet who actually developed the theory and has documented the extensive evidence in an upcoming academic book. So, what can we learn from this in the short term? Clearly, Google was not the only corporation triggered by Joe Rogan podcast # 1757 which previously reached #1 podcast ranking worldwide, has been referred to as the most important interview of our time and has been seen by over 50 million viewers.

Pfizer (PFE) announced the FDA approval of its Janus kinase 1 (JAK1) inhibitor CIBINQO (abrocitinib) as a treatment for adults with refractory, moderate-to-severe atopic